Nucleus Hybrid L24 Implant System
FDA premarket approval P130016/S028 · decided 2017-11-17
Approval details
- PMA number
- P130016
- Supplement
- S028
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Nucleus Hybrid L24 Implant System
- Generic name
- Cochlear implant with combined electrical stimulation and acoustic amplification
- Applicant
- Cochlear Americas
- Date received
- 2017-05-23
- Decision date
- 2017-11-17
- Days to decision
- 178 days
- Decision code
- APPR
- Product code
- PGQ
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Lone Tree, CO
- Statement
- Approval order for the remote programing of Nucleus Hybrid L24 Implant System using telehealth technology should be issued.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.